Management of infections due to antibiotic-resistant Streptococcus pneumoniae

S L Kaplan1, E O Mason

  • 1Section of Pediatric Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA. skaplan@bcm.tmc.edu

Insights

Antibiotic resistance in Streptococcus pneumoniae is increasing globally, necessitating updated treatment strategies. This review examines current recommendations for managing S. pneumoniae infections, particularly acute otitis media, focusing on emerging drug-resistant strains.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Increasing global prevalence of antibiotic-resistant Streptococcus pneumoniae strains.
  • Need for evolving treatment strategies for systemic S. pneumoniae infections like pneumonia and bacteremia.
  • Limited clinical efficacy data for new antibiotics against resistant S. pneumoniae isolates.

Purpose of the Study:

  • To review studies informing current treatment recommendations for S. pneumoniae infections.
  • To discuss evolving strategies for systemic infections.
  • To provide recommendations for treating acute otitis media caused by drug-resistant S. pneumoniae.

Main Methods:

  • Review of existing studies and clinical data.
  • Analysis of treatment guidelines for bacterial meningitis.
  • Evaluation of recommendations for pneumonia, bacteremia, and musculoskeletal infections.
  • Focus on otitis media treatment strategies.

Main Results:

  • Bacterial meningitis management shows consensus.
  • Treatment strategies for other infections are evolving due to new antibiotics.
  • Clinical efficacy data for new agents against resistant S. pneumoniae are limited.
  • Otitis media is the most common S. pneumoniae infection.

Conclusions:

  • Current recommendations for S. pneumoniae infections are based on reviewed studies.
  • New antibiotics show in vitro activity but limited clinical data exist.
  • Specific recommendations for acute otitis media due to drug-resistant S. pneumoniae are discussed.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...